FDA Grants Accelerated Approval to Ziihera for Some People With Biliary Tract Cancer

The FDA granted accelerated approval to zanidatamab-hrii (Ziihera, Jazz Pharmaceuticals), a bispecific ...

NOVEMBER 25, 2024